Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Teun van Gelder

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Living Beings

Tissue Donors

Anatomy

Kidney

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
van der Sijs Heleen; Lammers Laureen; van den Tweel Annemieke; Aarts Jos; Berg Marc; Vulto Arnold; van Gelder Teun
Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication error reductions.
Bijl Monique J; van Schaik Ron H N; Lammers Laureen A; Hofman Albert; Vulto Arnold G; van Gelder Teun; Stricker Bruno H Ch; Visser Loes E
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
Sombogaard Ferdi; Peeters Annemiek M A; Baan Carla C; Mathot Ron A A; Quaedackers Monique E; Vulto Arnold G; Weimar Willem; van Gelder Teun
Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Teun van Gelder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: van der Sijs Heleen; Lammers Laureen; van den Tweel Annemieke; Aarts Jos; Berg Marc; Vulto Arnold; van Gelder Teun
Time-dependent drug-drug interaction alerts in care provider order entry: software may inhibit medication error reductions.
Journal of the American Medical Informatics Association : JAMIA 2009;16(6):864-8.
2009: Bijl Monique J; van Schaik Ron H N; Lammers Laureen A; Hofman Albert; Vulto Arnold G; van Gelder Teun; Stricker Bruno H Ch; Visser Loes E
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
Breast cancer research and treatment 2009;118(1):125-30.
2009: Sombogaard Ferdi; Peeters Annemiek M A; Baan Carla C; Mathot Ron A A; Quaedackers Monique E; Vulto Arnold G; Weimar Willem; van Gelder Teun
Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not.
Therapeutic drug monitoring 2009;31(5):549-56.
2009: de Winter Brenda C M; van Gelder Teun; Mathot Ron A A; Glander Petra; Tedesco-Silva Helio; Hilbrands Luuk; Budde Klemens; van Hest Reinier M
Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.
Therapeutic drug monitoring 2009;31(5):585-91.
2009: van der Sijs Heleen; Mulder Alexandra; van Gelder Teun; Aarts Jos; Berg Marc; Vulto Arnold
Drug safety alert generation and overriding in a large Dutch university medical centre.
Pharmacoepidemiology and drug safety 2009;18(10):941-7.
2009: Teichert Martina; Eijgelsheim Mark; Rivadeneira Fernando; Uitterlinden Andre G; van Schaik Ron H N; Hofman Albert; De Smet Peter A G M; van Gelder Teun; Visser Loes E; Stricker Bruno H Ch
A genome-wide association study of acenocoumarol maintenance dosage.
Human molecular genetics 2009;18(19):3758-68.
2009: van Schaik R H N; van Agteren M; de Fijter J W; Hartmann A; Schmidt J; Budde K; Kuypers D; Le Meur Y; van der Werf M; Mamelok R; van Gelder T
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
Clinical pharmacology and therapeutics 2009;86(3):319-27.
2009: van der Sijs Heleen; Kowlesar Ravi; Aarts Jos; Berg Marc; Vulto Arnold; van Gelder Teun
Unintended consequences of reducing QT-alert overload in a computerized physician order entry system.
European journal of clinical pharmacology 2009;65(9):919-25.
2009: Kwadijk-de Gijsel Sonja; Bijl Monique J; Visser Loes E; van Schaik Ron H N; Hofman Albert; Vulto Arnold G; van Gelder Teun; Ch Stricker Bruno H
Variation in the CYP2D6 gene is associated with a lower serum sodium concentration in patients on antidepressants.
British journal of clinical pharmacology 2009;68(2):221-5.
2009: Sombogaard Ferdi; van Schaik Ron H N; Mathot Ron A; Budde Klemens; van der Werf Marloes; Vulto Arnold G; Weimar Willem; Glander Petra; Essioux Laurent; van Gelder Teun
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism.
Pharmacogenetics and genomics 2009;19(8):626-34.
2009: van Gelder T
Mycophenolate blood level monitoring: recent progress.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(7):1495-9.
2009: Epker Jelle L; van Biezen Paula; van Daele Paul L A; van Gelder Teun; Vossen Ann; van Saase Jan L C M
Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states.
European journal of internal medicine 2009;20(3):261-7.
2009: Bijl Monique J; Luijendijk Hendrika J; van den Berg Julia F; Visser Loes E; van Schaik Ron H N; Hofman Albert; Vulto Arnold G; van Gelder Teun; Tiemeier Henning; Stricker Bruno H Ch
Association between the CYP2D6*4 polymorphism and depression or anxiety in the elderly.
Pharmacogenomics 2009;10(4):541-7.
2009: van Gelder Teun; Domke Ingrid; Engelmayer Jutta; de Fijter Hans; Kuypers Dirk; Budde Klemens; Koeger Robin; Luthe Hilmar; Oellerich Michael
Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method.
Therapeutic drug monitoring 2009;31(2):218-23.
2009: van der Sijs Heleen; Kowlesar Ravi; Klootwijk A Peter J; Nelwan Stefan P; Vulto Arnold G; van Gelder Teun
Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study.
British journal of clinical pharmacology 2009;67(3):347-54.
2009: Roefs Anne; van der Ende Marchina; IJzermans Jan; Weimar Willem; van Gelder Teun
Long-term survival after kidney transplantation in an HIV-positive patient.
Clinical transplantation 2009;23(2):278-81.
2009: van Hest Reinier M; van Gelder Teun; Vulto Arnold G; Shaw Leslie M; Mathot Ron A A
Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.
Clinical pharmacokinetics 2009;48(7):463-76.
2008: van Gelder Teun; Silva Helio Tedesco; de Fijter Johan W; Budde Klemens; Kuypers Dirk; Tyden Gunnar; Lohmus Aleksander; Sommerer Claudia; Hartmann Anders; Le Meur Yann; Oellerich Michael; Holt David W; Tönshoff Burkhard; Keown Paul; Campbell Scott; Mamelok Richard D
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial.
Transplantation 2008;86(8):1043-51.
2008: Heijns Joan B; van der Burg Maria E L; van Gelder Teun; Fieren Marien W J A; de Bruijn Peter; van der Gaast Ate; Loos Walter J
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
Cancer chemotherapy and pharmacology 2008;62(5):841-7.
2008: van Agteren Madelon; Armstrong Victor W; van Schaik Ron H N; de Fijter Hans; Hartmann Anders; Zeier Martin; Budde Klemens; Kuypers Dirk; Pisarski Przemyslav; Le Meur Yann; van der Werf Marloes; Mamelok Richard D; Oellerich Michael; van Gelder Teun
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
Therapeutic drug monitoring 2008;30(4):439-44.
2008: de Jong F A; van der Bol J M; Mathijssen R H J; van Gelder T; Wiemer E A C; Sparreboom A; Verweij J
Renal function as a predictor of irinotecan-induced neutropenia.
Clinical pharmacology and therapeutics 2008;84(2):254-62.
2008: van der Sijs Heleen; Aarts Jos; van Gelder Teun; Berg Marc; Vulto Arnold
Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
Journal of the American Medical Informatics Association : JAMIA 2008;15(4):439-48.
2008: Hesselink Dennis A; van Schaik Ron H N; Nauta Jeroen; van Gelder Teun
A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
Pharmacogenomics 2008;9(6):783-9.
2008: Schenk P W; van Fessem M A C; Verploegh-Van Rij S; Mathot R A A; van Gelder T; Vulto A G; van Vliet M; Lindemans J; Bruijn J A; van Schaik R H N
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
Molecular psychiatry 2008;13(6):597-605.
2008: Hesselink Dennis A; van Schaik Ron H N; van Agteren Madelon; de Fijter Johannes W; Hartmann Anders; Zeier Martin; Budde Klemens; Kuypers Dirk R J; Pisarski Przemyslav; Le Meur Yann; Mamelok Richard D; van Gelder Teun
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.
Pharmacogenetics and genomics 2008;18(4):339-48.
2008: Bijl Monique J; Visser Loes E; Hofman Albert; Vulto Arnold G; van Gelder Teun; Stricker Bruno H Ch; van Schaik Ron H N
Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants.
British journal of clinical pharmacology 2008;65(4):558-64.
2008: de Winter Brenda C M; van Gelder Teun; Glander Petra; Cattaneo Dario; Tedesco-Silva Helio; Neumann Irmgard; Hilbrands Luuk; van Hest Reinier M; Pescovitz Mark D; Budde Klemens; Mathot Ron A A
Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.
Clinical pharmacokinetics 2008;47(12):827-38.
2008: Becker Matthijs L; Visser Loes E; van Gelder Teun; Hofman Albert; Stricker Bruno H Ch
Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years.
Drugs & aging 2008;25(2):145-52.
2007: van Hest Reinier M; Doorduijn Jeanette K; de Winter Brenda C M; Cornelissen Jan J; Vulto Arnold G; Oellerich Michael; Löwenberg Bob; Mathot Ron A A; Armstrong Victor William; van Gelder Teun
Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.
Therapeutic drug monitoring 2007;29(3):353-60.
2007: van Hest Reinier M; van Gelder Teun; Bouw René; Goggin Timothy; Gordon Robert; Mamelok Richard D; Mathot Ron A
Time-dependent clearance of mycophenolic acid in renal transplant recipients.
British journal of clinical pharmacology 2007;63(6):741-52.
2007: de Winter Brenda C M; Mathôt Ron A A; van Hest Reinier M; van Gelder Teun
Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?
Expert opinion on drug metabolism & toxicology 2007;3(2):251-61.
2006: Roodnat Joke I; van Gurp Eveline A F J; Mulder Paul G H; van Gelder Teun; de Rijke Yolanda B; de Herder Wouter W; Kal-van Gestel Judith A; Pols Huib A P; Ijzermans Jan N M; Weimar Willem
High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.
Transplantation 2006;82(3):362-7.
2006: van Gelder Teun; Le Meur Yann; Shaw Leslie M; Oellerich Michael; DeNofrio David; Holt Curtis; Holt David W; Kaplan Bruce; Kuypers Dirk; Meiser Bruno; Toenshoff Burkhard; Mamelok Richard D
Therapeutic drug monitoring of mycophenolate mofetil in transplantation.
Therapeutic drug monitoring 2006;28(2):145-54.
2006: van Hest Reinier M; Hesselink Dennis A; Vulto Arnold G; Mathot Ron A A; van Gelder Teun
Individualization of mycophenolate mofetil dose in renal transplant recipients.
Expert opinion on pharmacotherapy 2006;7(4):361-76.
2006: van Hest Reinier M; Mathot Ron A A; Pescovitz Mark D; Gordon Robert; Mamelok Richard D; van Gelder Teun
Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.
Journal of the American Society of Nephrology : JASN 2006;17(3):871-80.
2006: van Hest Reinier M; Mathot Ron A; Vulto Arnold G; Ijzermans Jan N; van Gelder Teun
Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.
Therapeutic drug monitoring 2006;28(1):31-4.
2005: van Gelder Teun; Shaw Leslie M
The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation.
Transplantation 2005;80(2 Suppl):S244-53.
2005: Hesselink Dennis A; van Gelder Teun
Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acid.
Clinical pharmacology and therapeutics 2005;78(4):317-21.
2005: Tha-In Thanyalak; Hesselink Dennis A; Tilanus Hugo W; Elshove Lara; Wilschut Anneloes L; Hansen Bettina E; van Gelder Teun; Metselaar Herold J
Clinical outcome after cyclosporine dose reduction based on C2 levels in long-term liver transplant patients.
Clinical transplantation 2005;19(4):537-42.
2005: Hesselink Dennis A; van Gelder Teun; van Schaik Ron Hn
The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?
Pharmacogenomics 2005;6(4):323-37.
2005: Hesselink Dennis A; van Hest Reinier M; Mathot Ron A A; Bonthuis Fred; Weimar Willem; de Bruin Ron W F; van Gelder Teun
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(5):987-94.
2005: van Hest Reinier; Mathot Ron; Vulto Arnold; Weimar Willem; van Gelder Teun
Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation.
Therapeutic drug monitoring 2005;27(2):163-7.
2005: van Hest Reinier M; van Gelder Teun; Vulto Arnold G; Mathot Ron A A
Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
Clinical pharmacokinetics 2005;44(10):1083-96.
2004: Hesselink Dennis A; van Gelder Teun; van Schaik Ron H N; Balk Aggie H M M; van der Heiden Ilse P; van Dam Thea; van der Werf Marloes; Weimar Willem; Mathot Ron A A
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
Clinical pharmacology and therapeutics 2004;76(6):545-56.
2004: van Hest Reinier M; Mathôt Ron A A; Vulto Arnold G; Le Meur Yann; van Gelder Teun
Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy.
Therapeutic drug monitoring 2004;26(6):620-5.
2004: Hesselink D A; van Dam T; Metselaar H J; Balk A H M M; Mathôt R A A; Smak Gregoor P J H; Weimar W; van Gelder T
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
Transplant international : official journal of the European Society for Organ Transplantation 2004;17(9):495-504.
2004: van Gelder Teun; Hesselink Dennis A; van Hest Reinier M; Mathôt Ron A A; van Schaik Ron
Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?
Therapeutic drug monitoring 2004;26(4):343-6.
2004: Wabbijn Marike; Balk Aggie H M M; van Domburg Ron T; Vantrimpont Pascal J M J; van Riemsdijk Iza C; Baan Carla C; Weimar Willem; van Gelder Teun
Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2004;2(1):201-7.
2004: Roodnat J I; Mulder P G H; Tielens E Th; van Riemsdijk I C; van Gelder T; Weimar W
The Cox proportional hazards analysis in words: examples in the renal transplantation field.
Transplantation 2004;77(4):483-8.
2004: van Gelder T
Mycophenolate mofetil and post-transplant glomerular disease.
Nephron. Clinical practice 2004;98(3):c59-60.
2004: Van Gelder Teun; Warlé Michiel; Ter Meulen Rik G
Anti-interleukin-2 receptor antibodies in transplantation: what is the basis for choice?
Drugs 2004;64(16):1737-41.
2003: Hesselink Dennis A; van Schaik Ron H N; van der Heiden Ilse P; van der Werf Marloes; Gregoor Peter J H Smak; Lindemans Jan; Weimar Willem; van Gelder Teun
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
Clinical pharmacology and therapeutics 2003;74(3):245-54.
2003: Hesselink Dennis A; Ngyuen Hien; Wabbijn Marike; Gregoor Peter J H Smak; Steyerberg Ewout W; van Riemsdijk Iza C; Weimar Willem; van Gelder Teun
Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.
British journal of clinical pharmacology 2003;56(3):327-30.
2003: Siccama Reinold; Balk Aggie H M M; de Herder Wouter W; van Domburg Ron; Vantrimpont Pascal; van Gelder Teun
Amiodarone therapy before heart transplantation as a predictor of thyroid dysfunction after transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2003;22(8):857-61.
2003: Smak Gregoor P J H; van Gelder T; van Riemsdijk-van Overbeeke I C; Vossen A C T M; IJzermans J N M; Weimar W
Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrations.
Transplant infectious disease : an official journal of the Transplantation Society 2003;5(2):79-83.
2003: Roodnat J I; van Riemsdijk I C; Mulder P G H; Doxiadis I; Claas F H J; IJzermans J N M; van Gelder T; Weimar W
The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis.
Transplantation 2003;75(12):2014-8.
2003: Hesselink D A; van Hagen P M; Balk A H M M; van Hal P Th W; Weimar W; van Gelder T
[Twenty-five years of cyclosporin use in transplantation medicine]
Nederlands tijdschrift voor geneeskunde 2003;147(20):959-64.
2003: Baan C C; Balk A H M M; van Riemsdijk I C; Vantrimpont P J M J; Maat A P W M; Niesters H G M; Zondervan P E; van Gelder T; Weimar W
Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation.
Transplantation 2003;75(10):1704-10.
2003: van der Mast Barbara J; van Besouw Nicole M; Witvliet Marian D; de Kuiper Petronella; Smak Gregoor Peter; van Gelder Teun; Weimar Willem; Claas Frans H J
Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.
Transplantation 2003;75(6):871-7.
2003: Roodnat J I; Mulder P G H; Van Riemsdijk I C; IJzermans J N M; van Gelder T; Weimar W
Ischemia times and donor serum creatinine in relation to renal graft failure.
Transplantation 2003;75(6):799-804.
2003: Baan Carla; van Gelder Teun; Peeters Annemiek; Mol Wendy; Niesters Hubert; Weimar Willem; IJzermans Jan
Living kidney donors and hypoxia-inducible factor-1alpha.
Transplantation 2003;75(4):570-1.
2003: de Groot-Kruseman Hester A; Mol Wendy M; Niesters Hubert G M; Maat Alex P W; van Gelder Teun; Balk Aggie H M M; Weimar Willem; Baan Carla C
Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(1):9-14.
2002: Baan C C; Balk A H M M; van der Plas A J; van Gelder T; Vantrimpont P J M J; Maat L P W M; Weimar W
IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipients.
Transplantation proceedings 2002;34(8):3243-5.
2002: Hesse C J; Baan C C; Balk A H M M; Metselaar H J; Weimar W; van Gelder T
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
Transplantation proceedings 2002;34(7):2988-90.
2002: Engelbertink R; Smak Gregoor P; Hesse C; IJzermans J; Weimar W; van Gelder T
High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.
Transplantation proceedings 2002;34(7):2983-4.
2002: van Besouw N M; Balk A H M M; van Vliet M; van der Meide P H; Maat A P W M; van Gelder T; Baan C C; Weimar W
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation.
Transplantation proceedings 2002;34(7):2942-3.
2002: Hazebroek Eric J; Gommers Diederik; Schreve Michiel A; van Gelder Teun; Roodnat Joke I; Weimar Willem; Bonjer H Jaap; IJzermans Jan N M
Impact of intraoperative donor management on short-term renal function after laparoscopic donor nephrectomy.
Annals of surgery 2002;236(1):127-32.
2002: van Besouw N M; van der Mast B J; de Kuiper P; Smak regoor P J H; Vaessen Lenard M B; Ijzermans J N M; van Gelder T; Weimar W
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantation.
Clinical and experimental immunology 2002;128(2):388-93.
2002: Hazebroek Eric J; de Vos tot Nederveen Cappel Robert; Gommers Diederik; van Gelder Teun; Weimar Willem; Steyerberg Ewout W; Bonjer H Jaap; IJzermans Jan N M
Antidiuretic hormone release during laparoscopic donor nephrectomy.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(5):600-4; discussion 605.
2002: Smak Gregoor Peter J H; de Sévaux Ruud G L; Ligtenberg Gerry; Hoitsma Andries J; Hené Ronald J; Weimar Willem; Hilbrands Luuk B; van Gelder Teun
Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.
Journal of the American Society of Nephrology : JASN 2002;13(5):1365-73.
2002: Elhendy Abdou; van Domburg Ron T; Vantrimpont Pascal; Poldermans Don; Bax Jeroen J; van Gelder Teun; Baan Carla C; Schinkel A; Roelandt Jos R T C; Balk Aggie H M M
Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging.
The American journal of cardiology 2002;89(8):964-8.
2002: van Gelder Teun
Drug interactions with tacrolimus.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(10):707-12.
2001: Weimar W; van Riemsdijk I C; Smak Gregoor P J; van Gelder T
Anti-CD25 prophylaxis allows steroid free kidney transplantation.
Transplantation proceedings 2001;33(7-8):3176-7.
2001: van der Mast B J; van Besouw N M; de Kuiper P; Vaessen L M; Gregoor P J; IJzermans J N; van Gelder T; Claas F H; Weimar W
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
Transplantation 2001;72(5):873-80.
2001: Roodnat J I; Mulder P G; Rischen-Vos J; van Riemsdijk I C; van Gelder T; Zietse R; IJzermans J N; Weimar W
Proteinuria after renal transplantation affects not only graft survival but also patient survival.
Transplantation 2001;72(3):438-44.
2001: de Sévaux R G; Gregoor P J; Hené R J; Hoitsma A J; Vos P; Weimar W; Van Gelder T; Hilbrands L B
A controlled trial comparing two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids.
Journal of the American Society of Nephrology : JASN 2001;12(8):1750-7.
2001: van Besouw N M; van der Mast B J; de Kuiper P; Smak Gregoor P J; Vaessen L M; IJzermans J N; van Gelder T; Weimar W
T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy.
Transplantation proceedings 2001;33(3):2239-40.
2001: Hesse C J; Vantrimpont P; van Riemsdijk-van Overbeeke I C; van Gelder T; Balk A H; Weimar W
The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
Transplantation proceedings 2001;33(3):2163-4.
2001: Vaessen L M; van Miert P P; van Gelder T; Ijzermans J N; Weimar W
Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
Transplantation 2001;71(8):1175-9.
2001: Roodnat J I; Mulder P G; Rischen-Vos J; van Riemsdijk I C; van Gelder T; Zietse R; Ijzermans J N; Weimar W
Proteinuria and death risk in the renal transplant population.
Transplantation proceedings 2001;33(1-2):1170-1.
2000: Smak Gregoor P J; van Gelder T; Weimar W
Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
The Netherlands journal of medicine 2000;57(6):233-46.
2000: Smak Gregoor P J; van Gelder T; van Besouw N M; van der Mast B J; IJzermans J N; Weimar W
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
Transplantation 2000;70(1):143-8.
2000: van Besouw N M; van der Mast B J; de Kuiper P; Smak Gregoor P J; Vaessen L M; IJzermans J N; van Gelder T; Weimar W
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
Transplantation 2000;70(1):136-43.
2000: Baan C C; van Gelder T; Balk A H; Knoop C J; Holweg C T; Maat L P; Weimar W
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection.
Transplantation 2000;69(3):331-6.
2000: Roodnat J I; Zietse R; Mulder P G; Rischen-Vos J; van Gelder T; Ijzermans J N; Weimar W
The impact of donor age on renal graft survival.
Transplantation proceedings 2000;32(1):136-8.
2000: van der Mast B J; van Besouw N M; de Kuiper P; Vaessen L M; IJzermans J N; van Gelder T; Weimar W
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZA.
Clinical transplantation 2000;14(1):66-9.
2000: Smak Gregoor P J; van Gelder T; van Besouw N M; van der Mast B J; Hesse C J; IJzermans J N; Weimar W
Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocol.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S333-5.
1999: Gregoor P J; de Sévaux R G; Hené R J; Hesse C J; Hilbrands L B; Vos P; van Gelder T; Hoitsma A J; Weimar W
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
Transplantation 1999;68(10):1603-6.
1999: Baan C C; Knoop C J; Holweg C T; van Gelder T; Metselaar H J; Niesters H G; Zondervan P E; Balk A H; Weimar W
The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation.
Transplantation proceedings 1999;31(7):2726-8.
1999: van Besouw N M; van der Mast B J; Smak Gregoor P J; Hesse C J; IJzermans J N; van Gelder T; Weimar W
Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(11):2710-3.
1999: Gregoor P J; van Gelder T; van der Ende M E; Ijzermans J N; Weimar W
Cyclosporine and triple-drug treatment with human immunodeficiency virus protease inhibitors.
Transplantation 1999;68(8):1210.
1999: van Gelder T; Hilbrands L B; Vanrenterghem Y; Weimar W; de Fijter J W; Squifflet J P; Hené R J; Verpooten G A; Navarro M T; Hale M D; Nicholls A J
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
Transplantation 1999;68(2):261-6.
1999: Baan C C; Knoop C J; van Gelder T; Holweg C T; Niesters H G; Smeets T J; van der Ham F; Zondervan P E; Maat L P; Balk A H; Weimar W
Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation.
Transplantation 1999;67(6):870-6.
1999: Smak Gregoor P J; van Gelder T; Hesse C J; van der Mast B J; van Besouw N M; Weimar W
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(3):706-8.
1999: Roodnat J I; Zietse R; Rischen-Vos J; van Gelder T; Mulder P G; IJzermans J N; Weimar W
Effect of race on kidney transplant survival in non-European recipients.
Transplantation proceedings 1999;31(1-2):312-3.
1999: Roodnat J I; Zietse R; Mulder P G; Rischen-Vos J; van Gelder T; IJzermans J N; Weimar W
The vanishing importance of age in renal transplantation.
Transplantation 1999;67(4):576-80.
1999: Roodnat J I; Zietse R; Rischen-Vos J; van Gelder T; Mulder P G; Ijzermans J N; Weimar W
Renal graft survival in native and non-native European recipients.
Transplant international : official journal of the European Society for Organ Transplantation 1999;12(2):135-40.
1998: van Gelder T; Balk A H; Zietse R; Hesse C; Mochtar B; Weimar W
Renal insufficiency after heart transplantation: a case-control study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(9):2322-6.
1998: van Gelder T; Gregoor P J; Hené R J; De Sévaux R G; Hilbrands L B
[Mycophenolic acid: a welcome adjunct immunosuppressant after organ transplants]
Nederlands tijdschrift voor geneeskunde 1998;142(27):1550-4.
1998: Roodnat J I; Zietse R; Rischen-Vos J; van Gelder T; IJzermans J N; Weimar W
Randomized trial to evaluate the use of increasing the steroid dose during conversion from cyclosporine to azathioprine.
Transplantation proceedings 1998;30(4):1199-200.
1998: Smak Gregoor P J; Hesse C J; van Gelder T; van der Mast B J; IJzermans J N; van Besouw N M; Weimar W
Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
Transplantation proceedings 1998;30(4):1192-3.
1998: van Gelder T; Balk A H; Zietse R; Hesse C; Mochtar B; Weimer W
Survival of heart transplant recipients with cyclosporine-induced renal insufficiency.
Transplantation proceedings 1998;30(4):1122-3.
1998: Baan C C; Knoop C J; van Gelder T; van der Ham F; Zondervan P E; Holweg C T; Mochtar B; Balk A H; Weimar W
Contribution of the inflammatory response to cardiac allograft rejection: histopathologic analysis of serial endomyocardial biopsies.
Transplantation proceedings 1998;30(4):1104-6.
1998: Baan C C; Holweg C T; Niesters H G; van Gelder T; Mol W M; Zondervan P E; Mochtar B; Balk A H; Weimar W
The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(4):363-73.
1998: Klaassen R J; van Gelder T; de Meester J; Deinum J; Weimar W
Incidence of posttransplant erythrocytosis (PTE) in kidney graft recipients where the recipient of the contralateral kidney developed PTE.
Transplantation 1998;65(8):1138-9.
1998: van Gelder T; Baan C C; Balk A H; Knoop C J; Holweg C T; van der Meer P; Mochtar B; Zondervan P E; Niesters H G; Weimar W
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans.
Transplantation 1998;65(3):405-10.
1998: van Gelder T; Balk A H; Zondervan P E; Maat A W; Mochtar B; van der Meer P; Weimar W
C-reactive protein in the monitoring of acute rejection after heart transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11(5):361-4.
1998: Baan C C; Holweg C H; van Gelder T; Knoop C J; Niesters H G; Zondervan P; Mochtar B; Balk A H; Weimar W
Redundancy of the cytokine network in the development of rejection after clinical heart transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11 Suppl 1():S512-4.
1998: van Besouw N M; Daane C R; de Kuiper P; van Gelder T; Mochtar B; Balk A H; Vaessen L M; Weimar W
Donor-specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11 Suppl 1():S364-6.
1998: van Riemsdijk-van Overbeeke I C; Baan C C; Loonen E H; Hesse C J; Zietse R; van Gelder T; Weimar W
The TNF-alpha system after successful living-related kidney transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11 Suppl 1():S46-9.
1997: Smak Gregoor P J; van Gelder T; Abraham Tanis A; Chadha-Ajwani S; Klaassen R J; Weimar W
Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(12):2766-7.
1997: Klaassen R J; van Gelder T; Rischen-Vos J; Deinum J; Man in't Veld A J; Weimar W
Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.
Transplantation 1997;64(5):780-2.
1997: van Besouw N M; Daane C R; Vaessen L M; van Gelder T; Mochtar B; Balk A H; Weimar W
Nonspecific immune reactivity of peripheral blood mononuclear cells is related to graft vascular disease.
Transplantation proceedings 1997;29(6):2544-5.
1997: Baan C C; Holweg C T; Niesters H G; van Gelder T; Mol W M; Mochtar B; Balk A H; Weimar W
Intragraft cytokine and growth factor mRNA expression in relation to graft vascular disease after heart transplantation.
Transplantation proceedings 1997;29(6):2535-6.
1997: van Gelder T; Klaassen R J; van Riemsdijk-van Overbeeke I; IJzermans J N; Weimar W
Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.
Transplantation 1997;63(10):1530-1.
1996: Baan C C; Niesters H G; Balk A H; Mochtar B; Zondervan P E; van Gelder T; Weimar W
Steroid resistance in clinical heart transplantation: the role of simultaneous IL-2 and IL-4 mRNA expression.
Transplantation proceedings 1996;28(6):3239-40.
1996: van Gelder T; Zietse R; Yzermans J N; Rischen-Vos J; Vaessen L M; Weimar W
Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
Transplantation proceedings 1996;28(6):3221-2.
1996: van Gelder T; Balk A H; Jonkman F A; Zietse R; Zondervan P; Hesse C J; Vaessen L M; Mochtar B; Weimar W
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation.
Transplantation 1996;62(1):51-5.
1996: van Gelder T; Jonkman F A; Niesters H G; Vuzevski V D; Spillenaar Bilgen E J; Weimar W
Absence of Epstein-Barr virus involvement in an adult heart transplant recipient with an epitheloid leiomyosarcoma.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1996;15(6):650-1.
1995: Hesse C J; van Gelder T; Vaessen L M; Knoop C J; Balk A H; Yzermans J N; Jutte N H; Weimar W
Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantation.
Immunopharmacology 1995;30(3):237-46.
1995: van Gelder T; Zietse R; Mulder A H; Yzermans J N; Hesse C J; Vaessen L M; Weimar W
A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation.
Transplantation 1995;60(3):248-52.
1995: van Gelder T; Mulder A H; Balk A H; Mochtar B; Hesse C J; Baan C C; Vaessen L M; Weimar W
Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1995;14(2):346-50.
1995: van Gelder T; Knoop C J; Hesse C J; Vaessen L M; Balk A H; Yzermans J N; Weimar W
Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
Transplantation proceedings 1995;27(1):856-8.
1995: Marsman W A; Van Gelder T; Mulder A H; Ijzermans J N; Zietse R; Weimar W
Successful treatment of Kaposi's sarcoma in a renal allograft recipient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(6):900-1.
1994: van Gelder T; Kroes L C; Mulder A; Gratama J W; Weimar W
A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation.
Transplantation 1994;58(7):852-5.
1994: Van Gelder T; Daane C R; Vaessen L M; Hesse C J; Mochtar B; Balk A H; Weimar W
In vitro and in vivo effects of BT 563, an anti-interleukin-2 receptor monoclonal antibody.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S556-8.
1993: Van Leeuwen M L; Van Gelder T; Van Gemert H M; Weimar W
Cortical blindness due to cyclosporin.
The Netherlands journal of medicine 1993;43(1-2):69-70.
1991: van Gelder T; van Gemert H M; Staal A
[Horner's syndrome: can we turn a blind eye?]
Nederlands tijdschrift voor geneeskunde 1991;135(32):1432-4.
1991: van Gelder T; van Gemert H M; Tjiong H L
A patient with megaloblastic anaemia and idiopathic intracranial hypertension. Case history.
Clinical neurology and neurosurgery 1991;93(4):321-2.
1990: van Gelder T; Kroes A C; van der Ende M E
Acute HIV-infection: report of a case and a review of recent developments.
The Netherlands journal of medicine 1990;37(3-4):154-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Teun van Gelder

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Living Beings

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Teun van Gelder (preview)

All Publications